FluoGuide: First patient enrolled in US Phase II registration-supporting trial
Redeye comments on FluoGuide's announcement that the first patient has been enrolled in FG001-CT-006, the company's US Phase II trial of FG001 in...
90 Views
FluoGuide: Collaboration with Leica Microsystems expands microscope coverage
Redeye comments on FluoGuide's announcement of a collaboration with Leica Microsystems to optimize the use of Leica's imaging systems together...
84 Views
FluoGuide (Q2 Review): Building on its repertoire of clinical evidence
Redeye comments on Fluoguide’s recently published Q2 2026 report. The financials did not contain any major surprises. While OPEX came in slightly...
83 Views
FluoGuide: First part of Phase 2 HNC trial clears dose-finding phase
Redeye comments on FluoGuide announcing results from the first part of the ongoing CT-005 trial evaluating FG001 for surgical guidance in patients...
83 Views
FluoGuide (Q1 Review): Catalyst-Heavy Remainder of 2026
Redeye comments on Fluoguide’s Q1 2026 report. The quarter was marked by two consecutive FDA decisions that together define the near-term roadmap:...
85 Views